Passage Bio Inc’s filing revealed that its CHIEF MEDICAL OFFICER Forman Mark S unloaded Company’s shares for reported $1589.0 on Feb 13 ’24. In the deal valued at $0.97 per share,1,638 shares were sold. As a result of this transaction, Forman Mark S now holds 48,631 shares worth roughly $64192.920000000006.
Then, Borthwick Kathleen sold 1,470 shares, generating $1,426 in total proceeds. Upon selling the shares at $0.97, the SVP, INTERIM CFO now owns 28,466 shares.
Before that, Forman Mark S sold 15,813 shares. Passage Bio Inc shares valued at $14,390 were divested by the Chief Medical Officer at a price of $0.91 per share. As a result of the transaction, Forman Mark S now holds 45,269 shares, worth roughly $59755.08.
JP Morgan downgraded its Passage Bio Inc [PASG] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in mid January from “a Buy” to “a Neutral”. Raymond James began covering PASG with “an Outperform” recommendation on July 01, 2021. BTIG Research started covering the stock on June 15, 2021. It rated PASG as “a Buy”.
Price Performance Review of PASG
On Tuesday, Passage Bio Inc [NASDAQ:PASG] saw its stock fall -2.22% to $1.32. Over the last five days, the stock has gained 1.54%. Passage Bio Inc shares have risen nearly 30.69% since the year began. Nevertheless, the stocks have risen 26.92% over the past one year. While a 52-week high of $1.79 was reached on 03/06/24, a 52-week low of $0.58 was recorded on 01/25/24. SMA at 50 days reached $1.3120, while 200 days put it at $0.9161. A total of 0.28 million shares were traded, compared to the trading of 0.12 million shares in the previous session.
Levels Of Support And Resistance For PASG Stock
The 24-hour chart illustrates a support level at 1.2432, which if violated will result in even more drops to 1.1665. On the upside, there is a resistance level at 1.3835. A further resistance level may holdings at 1.4471. The Relative Strength Index (RSI) on the 14-day chart is 47.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0063, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.50%. Stochastics %K at 34.17% indicates the stock is a holding.
How much short interest is there in Passage Bio Inc?
A steep rise in short interest was recorded in Passage Bio Inc stocks on Mar 15, 2024, growing by 0.96 million shares to a total of 1.21 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.25 million shares. There was a rise of 79.24%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 2.75% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.16.
